© 2024 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
Kristie L. Kahl is vice president of content at MJH Life Sciences, overseeing CURE®, CancerNetwork®, the journal ONCOLOGY, Targeted Oncology, and Urology Times®. She has been with the company since November 2017.
Now a 10-year survivor of bone cancer, Dana Vaughns chose to triumph over his disease and joined Bristol-Myers Squibb on its Coast 2 Coast 4 Cancer ride.
After being diagnosed with bone cancer, Dana Vaughns refused to own his cancer, and instead triumphed over the disease.
Now a 10-year survivor, he recently joined 109 of his colleagues from Bristol-Myers Squibb in riding 225 miles each as part of the V Foundation’s Coast 2 Coast 4 Cancer ride.
“(Participating in events like this is) important because we ensure that we're staying in front of this thing called cancer,” Vaughns said. “…We have to find a way to be able to come up with solutions for cancer, whether they be cured, whether they be better treatments, we just have to ensure that we stay out there because the next person that may be diagnosed is going to rely on that…It is very important that we're not just doing this for now, but we're doing it for tomorrow.”
In this week’s episode, CURE spoke with Vaughns about his journey with cancer and his triumph over the disease — including his recent trek that he considers exhilarating.
Related Content: